Certara’s Vaccine Simulator is a cutting-edge tool that employs Quantitative Systems Pharmacology (QSP) modeling to determine optimal vaccine dosing strategies. By integrating data from extensive clinical studies, the Vaccine Simulator develops sophisticated models to answer critical “what-if” scenarios. Using 32 clinical datasets, 3 vaccines, 8 dosing regimens, and 10 biomarkers, a novel model was developed. This model is instrumental in identifying the best dosing strategies for various patient groups, including vulnerable populations like the elderly and children. Trusted by global pharmaceutical companies, the Vaccine Simulator has been presented to regulatory agencies, including the FDA, showcasing its reliability and impact.
Vaccine Simulator
Optimize vaccine strategies for better patient outcomes
Learn more about the Vaccine Simulator
QSP model to guide and inform vaccine dosing
Certara’s Vaccine Simulator is built on a robust foundation of QSP technology, calibrated with data from over 20 clinical cases. This innovative platform allows pharmaceutical companies to simulate trial outcomes, predict vaccine efficacy, and optimize dosing regimens.
对话 QSP 专家
相关资源
查看全部Explore our other QSP platform models
Certara 提供覆盖多疾病领域的定量系统药理学(QSP)平台模型,通过数据驱动的洞见加速药物开发。我们的定制化方案整合复杂生物系统,支持从研究到临床的全链条决策优化。
Speak to a QSP expert
Learn about how Certara’s Vaccine Simulator can transform your vaccine development process.